Form 4: Brian Christopher Miller Reports Acquisition of Beauty Health Co Stock
SEC Form 4 Filing
Director Brian Christopher Miller reported the acquisition of Beauty Health Co Class A Common Stock through a grant of restricted stock units.
Summary
- On July 8, 2024, Brian Christopher Miller, a director of Beauty Health Co, reported acquiring 78,534 shares of Class A Common Stock.
- These shares were obtained through a grant of restricted stock units (RSUs).
- Following the transaction, Miller directly owns 169,984 shares of Beauty Health Co.
- The RSUs vest on the earlier of July 8, 2025, or the date of the 2025 Annual Meeting of Stockholders, contingent upon continued service on the board.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The acquisition itself can be viewed slightly positively, indicating confidence.
Positives
- A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The vesting of the RSUs is contingent upon the reporting person's continued service as a member of the Company's board of directors through the vesting date.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for maintaining investor confidence.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of transaction: Acquisition of Class A Common Stock via RSUs. |
| 07/08/2025 | Earliest vesting date for RSUs, contingent on continued service. |
| 2025 Annual Meeting of Stockholders | Alternative vesting date for RSUs, contingent on continued service. |
| 07/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.